Travere Therapeutics, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Travere Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2013 to Q3 2024.
  • Travere Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$84K, a 800% decline year-over-year.
  • Travere Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $260K, a 19.3% increase year-over-year.
  • Travere Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $223K, a 28.8% decline from 2022.
  • Travere Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $313K, a 23.5% decline from 2021.
  • Travere Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $409K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $260K -$84K -$96K -800% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $356K $85K +$20K +30.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $336K $191K +$113K +145% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $223K $68K +$5K +7.94% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $218K $12K -$133K -91.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $351K $65K +$12K +22.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $339K $78K +$26K +50% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $313K $63K +$59K +1475% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $254K $145K +$102K +237% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $152K $53K +$4K +8.16% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $148K $52K -$261K -83.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $409K $4K +$475K Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 -$66K $43K +$20K +87% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 -$86K $49K -$16K -24.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$70K $313K +$19.3M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$19.4M -$471K -$503K -1572% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-01
Q3 2020 -$18.9M $23K +$546K Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 -$19.4M $65K -$4K -5.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 -$19.4M -$19M -$19.4M -4832% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$21K $32K +$32K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$53K -$523K -$938K -226% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-01
Q2 2019 $885K $69K -$98K -58.7% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-01
Q1 2019 $983K $401K +$172K +75.1% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-01
Q4 2018 $811K $0 -$6.58M -100% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-24
Q3 2018 $7.39M $415K +$1.64M Jul 1, 2018 Sep 30, 2018 10-K 2020-02-24
Q2 2018 $5.75M $167K +$2.09M Apr 1, 2018 Jun 30, 2018 10-K 2020-02-24
Q1 2018 $3.66M $229K +$2.29M Jan 1, 2018 Mar 31, 2018 10-K 2020-02-24
Q4 2017 $1.37M $6.58M +$10.3M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-26
Q3 2017 -$8.9M -$1.22M -$7.69M -119% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-26
Q2 2017 -$1.21M -$1.93M +$5.47M +74% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-26
Q1 2017 -$6.67M -$2.06M +$3.01M +59.3% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-26
Q4 2016 -$9.68M -$3.68M +$6.84M +65% Oct 1, 2016 Dec 31, 2016 10-K/A 2018-07-06
Q3 2016 -$16.5M $6.47M -$32.3M -83.3% Jul 1, 2016 Sep 30, 2016 10-K/A 2018-07-06
Q2 2016 $15.8M -$7.39M -$7.41M -49380% Apr 1, 2016 Jun 30, 2016 10-K/A 2018-07-06
Q1 2016 $23.2M -$5.07M +$35M +87.3% Jan 1, 2016 Mar 31, 2016 10-K/A 2018-07-06
Q4 2015 -$11.8M -$10.5M -$10.5M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-01
Q3 2015 -$1.25M $38.8M +$38.8M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-01
Q2 2015 -$40M $15K +$2.54M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-01
Q1 2015 -$42.5M -$40M -$40.1M -61671% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-01
Q4 2014 -$2.46M $0 -$75.8K -100% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-26
Q3 2014 -$2.38M $0 Jul 1, 2014 Sep 30, 2014 10-K 2016-02-26
Q2 2014 -$2.53M Apr 1, 2014 Jun 30, 2014 10-K 2016-02-26
Q1 2014 $65K Jan 1, 2014 Mar 31, 2014 10-K 2016-02-26
Q4 2013 $75.8K Oct 2, 2013 Dec 31, 2013 10-K 2015-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.